Merrimack Pharmaceuticals
MACK
#8378
Rank
โ‚น20.20 B
Marketcap
โ‚น1,367
Share price
0.00%
Change (1 day)
9.33%
Change (1 year)

Market capitalization of Merrimack Pharmaceuticals (MACK)

Last known market cap: โ‚น20.20 Billion

On July 19, 2024 Merrimack Pharmaceuticals had a market cap of โ‚น20.20 Billion. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Merrimack Pharmaceuticals from 2012 to 2025

End of year Market Cap

Year Marketcap Change
2025โ‚น20.20 B5.29%
2024โ‚น19.19 B20.06%
2023โ‚น15.98 B25.72%
2022โ‚น12.71 B225.85%
2021โ‚น3.90 B-42.12%
2020โ‚น6.74 B124.33%
2019โ‚น3.00 B-16.54%
2018โ‚น3.60 B-58.73%
2017โ‚น8.72 B-75.72%
2016โ‚น35.93 B-40.92%
2015โ‚น60.83 B-20.39%
2014โ‚น76.41 B126.3%
2013โ‚น33.76 B5.68%
2012โ‚น31.95 B

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Sanofi
SNY
โ‚น10.772 T 53,202.48%๐Ÿ‡ซ๐Ÿ‡ท France
AVEO Oncology
AVEO
โ‚น47.09 B 133.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Geron
GERN
โ‚น80.14 B 296.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Clovis Oncology
CLVS
โ‚น1.06 B-94.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
โ‚น1.04 B-94.81%๐Ÿ‡บ๐Ÿ‡ธ USA